Lexagene Holdings (Lexagene Holdings) Change In Receivables : $-0.01 Mil (TTM As of Nov. 2022)

View and export this data going back to 2017. Start your Free Trial

What is Lexagene Holdings Change In Receivables?

Lexagene Holdings's change in receivables for the quarter that ended in Nov. 2022 was $-0.03 Mil. It means Lexagene Holdings's Accounts Receivable increased by $0.03 Mil from Aug. 2022 to Nov. 2022 .

Lexagene Holdings's change in receivables for the fiscal year that ended in Feb. 2022 was $0.03 Mil. It means Lexagene Holdings's Accounts Receivable declined by $0.03 Mil from Feb. 2021 to Feb. 2022 .

Lexagene Holdings's Accounts Receivable for the quarter that ended in Nov. 2022 was $0.05 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Lexagene Holdings's Days Sales Outstanding for the three months ended in Nov. 2022 was 110.35.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Lexagene Holdings's liquidation value for the three months ended in Nov. 2022 was $-0.99 Mil.

Lexagene Holdings Change In Receivables Historical Data

The historical data trend for Lexagene Holdings's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lexagene Holdings Change In Receivables Chart

Lexagene Holdings Annual Data

Trend

Mar13

Mar14

Mar15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Change In Receivables

Get a 7-Day Free Trial

0.01

-0.04

0.03

Lexagene Holdings Quarterly Data
	Feb18	May18	Aug18	Nov18	Feb19	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22
Change In Receivables	Get a 7-Day Free Trial															-0.02	0.03	-0.01	-	-0.03

Lexagene Holdings Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Nov. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01 Mil.

Lexagene Holdings (OTCPK:LXXGQ) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Lexagene Holdings's Days Sales Outstanding for the quarter that ended in Nov. 2022 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	0.052	/	0.043	*	91
=	110.35

2. In Ben Graham's calculation of liquidation value, Lexagene Holdings's accounts receivable are only considered to be worth 75% of book value:

Lexagene Holdings's liquidation value for the quarter that ended in Nov. 2022 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	0.464	-	2.217	+	0.75 * 0.052	+	0.5 * 1.445
=	-0.99

Lexagene Holdings Change In Receivables Related Terms

Thank you for viewing the detailed overview of Lexagene Holdings's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Lexagene Holdings (Lexagene Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Lexagene Holdings Inc (OTCPK:LXXGQ) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

N/A

Address

500 Cummings Center, Suite 4550, Beverly, MA, USA, 01915

Website

https://www.lexagene.com

Lexagene Holdings Inc is a molecular diagnostics company that develops molecular diagnostic systems for pathogen detection and genetic testing for other molecular markers for on-site rapid testing in veterinary diagnostics, and for use in open-access markets such as food and water safety, clinical research, agricultural testing and biodefense. The MiQLab system delivers sensitivity, specificity, and breadth of detection and can return results in approximately two hours. The unique open-access feature is designed for custom testing so that end-users can load their own real-time PCR assays onto the instrument to target any genetic target of interest.